IP Library Granted Patent US 9,737,630
Granted Patent B2
US 9,737,630 · App. 14/635,215 · Granted Aug 22, 2017

Mechanically strong absorbable polymeric blend compositions of precisely controllable absorption rates, processing methods, and products therefrom

Inventors: Dennis D. Jamiolkowski (Long Valley, NJ); Daniel Steiger (Basking Ridge, NJ); Modesto Erneta (Princeton Junction, NJ)
Assignee: Ethicon, LLC
A61L17/12A61B17/06166A61L17/005A61L27/26A61L27/54B29C45/00B29C47/00B29C49/00C08J3/005C08L67/04A61B17/064A61B2017/00004A61L2300/202A61L2300/404A61L2300/606A61L2430/00B29L2031/753C08J2367/04C08J2467/04Y10T442/10Y10T442/3976Y10T442/40Y10T442/696
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,737,630
App. No.
14/635,215
Granted
Aug 22, 2017
Kind
B2
Abstract

Novel absorbable polymer blends are disclosed. The blends are useful for manufacturing medical devices having engineered degradation and breaking strength retention in vivo. The blends consist of a first absorbable polymeric component and a second absorbable polymeric component. The weight average molecular weight of the first polymeric component is higher than the weight average molecular weight of the second polymeric component. At least at least one of said components is at least partially end-capped by a carboxylic acid group. Further aspects are medical devices made therefrom.

Claims (28)

1. A suture, comprising an absorbable polymer blend, the blend comprising:

a mixture of a polymer and an oligomer, wherein the polymer has a weight average molecular weight higher than the weight average molecular weight of the oligomer, and wherein the weight average molecular weight of the oligomer is about 1,400 Daltons to about 5,200 Daltons,

wherein at least about 100% of the absorbable oligomer is end-capped on both ends by carboxylic acid groups and about 0% of the polymer is end-capped by carboxylic acid groups, and wherein a suture made from said blend and having a size has a pre-implantation strength equivalent to or greater than the pre-implantation strength of a similar suture one size larger, said similar suture consisting essentially of the first component, wherein said suture and said similar suture have a substantially equivalent time to achieve zero mechanical strength.

2. The suture of claim 1 , wherein the polymer blend has an inherent viscosity of about 0.5 dL/g to about 1.8 dL/g.

3. The suture of claim 1 , wherein the weight average molecular weight of the polymer blend is about 18,000 Daltons to about 100,000 Daltons.

4. The suture of claim 1 , said device coated with a medically useful substance.

5. The suture of claim 1 , wherein at least a part of the suture comprises a plurality of yarns or filaments.

6. The suture of claim 1 , wherein the suture is a monofilament.

7. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments a blend of poly(lactide-co-glycolide) copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about 12 wt. % of polymerized lactide, wherein the suture has a diameter of about 19 mils,

a minimum pre-implantation tensile strength of about 20 pounds,

a minimum tensile strength of about 12 pounds at 5 days post-implantation, substantially no tensile strength at 14 days post-implantation,

and wherein the suture is substantially absorbed in about 42 days post-implantation.

8. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments comprising a blend of poly(lactide-co-glycolide) copolymer, said copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about 12 wt. % of polymerized lactide,

wherein the suture has a diameter of about 16 mils, a minimum pre-implantation tensile strength of about 15 pounds, a minimum tensile strength of about 9.5 pounds at 5 days post-implantation, from substantially no tensile strength to about 5% of the pre-implantation tensile strength at 14 days post-implantation, and, wherein the suture is substantially absorbed in about 42 days post-implantation.

9. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments comprising a blend of poly(lactide-co-glycolide) copolymer, said copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about 12 wt. % of polymerized lactide,

wherein the suture has a diameter of about 13 mils, a minimum pre-implantation tensile strength of about 11 pounds, a minimum tensile strength of about 7 pounds at 5 days post-implantation, substantially no tensile strength at 14 days post-implantation, and, wherein the suture is substantially absorbed in about 42 days post-implantation.

10. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments comprising a blend of poly(lactide-co-glycolide) copolymer, said copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about wt. % 12 of polymerized lactide,

wherein the suture has a diameter of about 10 mils, a minimum pre-implantation tensile strength of about 7.5 pounds, a minimum tensile strength of about 4.5 pounds at 5 days post-implantation, substantially no tensile strength at 14 days post-implantation, and, wherein the suture is substantially absorbed in about 42 days post-implantation.

11. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments comprising a blend of poly(lactide-co-glycolide) copolymer, said copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about 12 wt. % of polymerized lactide,

wherein the suture has a diameter of about 8 mils, a minimum pre-implantation tensile strength of about 4.6 pounds, a minimum tensile strength of about 3 pounds at 5 days post-implantation, substantially no tensile strength at 14 days post-implantation, and, wherein the suture is substantially absorbed in about 42 days post-implantation.

12. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments comprising a blend of poly(lactide-co-glycolide) copolymer, said copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about 12 wt. % of polymerized lactide,

wherein the suture has a diameter of about 6 mils, a minimum pre-implantation tensile strength of about 2.6 pounds, a minimum tensile strength of about 1.6 pounds at 5 days post-implantation, substantially no tensile strength at 14 days post-implantation, and, wherein the suture is substantially absorbed in about 42 days post-implantation.

13. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments comprising a blend of poly(lactide-co-glycolide) copolymer, said copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about 12 wt. % of polymerized lactide,

wherein the suture has a diameter of about 3.3 mils, a minimum pre-implantation tensile strength of about 1.2 pound, a minimum tensile strength of about 0.75 pounds at 5 days post-implantation, substantially no tensile strength at 14 days post-implantation, and, wherein the suture is substantially absorbed in about 42 days post-implantation.

14. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments comprising a blend of poly(lactide-co-glycolide) copolymer, said copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about 12 wt. % of polymerized lactide,

wherein the suture has a diameter of about 2.4 mils, a minimum pre-implantation tensile strength of about 0.53 pounds, a minimum tensile strength of about 0.40 pounds at 5 days post-implantation, substantially no tensile strength at 14 days post-implantation, and, wherein the suture is substantially absorbed in about 42 days post-implantation.

15. The suture of claim 1 , wherein said suture comprises a plurality of filaments, the filaments comprising a blend of poly(lactide-co-glycolide) copolymer, the copolymer comprising about 88 wt. % to about 92 wt. % of polymerized glycolide and about 8 wt. % to about 12 wt. % of polymerized lactide,

wherein the suture has a diameter of about 1.8 mils, a minimum pre-implantation tensile strength of about 0.45 pounds, a minimum tensile strength of about 0.30 pounds at 5 days post-implantation, substantially no tensile strength at 14 days post-implantation, and, wherein the suture is substantially absorbed in about 42 days post-implantation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056601/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2015
From: ETHICON, INC.
To: ETHICON, LLC
Reel/Frame 037178/0183 →
Continuity (3)
Division 13833690 · Mar 15, 2013
Provisional Application 61651353 · May 24, 2012
Related Publication 20150174288A1 · Jun 25, 2015